Results 11 to 20 of about 109,169 (264)
Antiplatelet resistance in stroke [PDF]
Expert Review of Neurotherapeutics, 2011 Although the exact prevalence of antiplatelet resistance in ischemic stroke is not known, estimates about the two most widely used antiplatelet agents - aspirin and clopidogrel - suggest that the resistance rate is high, irrespective of the definition used and parameters measured. Inadequate antiplatelet responsiveness correlates with an increased risk
Mehmet Akif, Topçuoglu +2 more
openaire +4 more sources
Sorghum Protein Extract Protects RBC from Sodium Nitrite-Induced Oxidative Stress and Exhibits Anticoagulant and Antiplatelet Activity [PDF]
Folia Medica, 2021 Introduction: Oxidative stress plays a critical role in the progression of diabetes, arthritis, cancer, eryptosis, cardiovascular disease, and thrombosis. Currently, antioxidants from natural sources are in high demand due to their beneficial role in the
Devaraja Sannaningaiah +10 more
doaj +3 more sources
Российский кардиологический журнал, 2021 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment ...
J.-P. Collet +23 more
doaj +1 more source
Antithrombotic therapy after transcatheter aortic valve replacement
Heart Views, 2022 Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk.
Tariq A.M. Mousa +2 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Aims: In this pre-specified analysis of the “endothelium, stent and antiplatelet therapy” study, we investigate the impact of antiplatelet therapies on microvascular function in patients undergoing stenting for an acute coronary syndrome.Methods and ...
Boris Schnorbus +7 more
doaj +1 more source
Frontiers in Immunology, 2022 Patients with COVID-19 often have hypoxemia, impaired lung function, and abnormal imaging manifestations in acute and convalescent stages. Alveolar inflammation, pulmonary vasculitis, and thromboembolism synergistically damage the blood-air barrier ...
Mengqi Xiang +9 more
doaj +1 more source
Bridging therapy according to new clinical guidelines: A review
Consilium Medicum, 2022 In modern world it is really important to know how to manage patients taking anticoagulant or antiplatelet therapy. There is an increasing number of patients, who have gone through PCI or any other cardiac intervention and who also need another surgery ...
Tatiana A. Pavlenko +2 more
doaj +1 more source
British Journal of Pharmacology, 2006 British Journal of Pharmacology (2006) 147, S241–S251.
Gustav, Born, Carlo, Patrono
openaire +2 more sources
British Journal of Haematology, 2008 SummaryPlatelets play a major role in thromboembolic diseases, and so antiplatelet therapy remains crucial in treatment and prophylaxis. Upon vascular injury, platelets rapidly adhere to the exposed subendothelial matrix, after which they become activated, resulting in the recruitment of additional platelets from the circulation to eventually form a ...
Simon F, De Meyer +4 more
openaire +2 more sources
Frontiers in Surgery, 2023 IntroductionAround 20% of population in western countries is under anticoagulant treatment. However, there is paucity of evidence about the treatment of HD in patients under anticoagulant/antiplatelet therapy, although both suspension and continuation in
Francesco Pata +6 more
doaj +1 more source